 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
Calpain 1 proteolytic core in complex with snj-1945, a alpha-ketoamide-type inhibitor.
|
|
Structure:
|
 |
Calpain-1 catalytic subunit. Chain: a. Fragment: residues 27-356. Synonym: calpain-1 large subunit, calcium-activated neutral proteinase 1, canp 1, calpain mu-type, mucanp, micromolar-calpain. Engineered: yes
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: capn1, cls1. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
|
|
Resolution:
|
 |
|
1.61Å
|
R-factor:
|
0.198
|
R-free:
|
0.229
|
|
|
Authors:
|
 |
D.Cuerrier,T.Moldoveanu,P.L.Davies,R.L.Campbell
|
Key ref:
|
 |
D.Cuerrier
et al.
(2006).
Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
Biochemistry,
45,
7446-7452.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
02-Mar-06
|
Release date:
|
06-Jun-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P97571
(CAN1_RAT) -
Calpain-1 catalytic subunit
|
|
|
|
Seq: Struc:
|
 |
 |
 |
713 a.a.
322 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
intracellular
|
1 term
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
cysteine-type endopeptidase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
45:7446-7452
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
|
|
D.Cuerrier,
T.Moldoveanu,
J.Inoue,
P.L.Davies,
R.L.Campbell.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Calpains are intracellular calcium-activated cysteine proteases whose
unregulated proteolysis following the loss of calcium homeostasis can lead to
acute degeneration during ischemic episodes and trauma, as well as Alzheimer's
disease and cataract formation. The determination of the crystal structure of
the proteolytic core of mu-calpain (muI-II) in a calcium-bound active
conformation has made structure-guided design of active site inhibitors
feasible. We present here high-resolution crystal structures of rat muI-II
complexed with two reversible calpain-specific inhibitors employing cyclic
hemiacetal (SNJ-1715) and alpha-ketoamide (SNJ-1945) chemistries that reveal new
details about the interactions of inhibitors with this enzyme. The SNJ-1715
complex confirms that the free aldehyde is the reactive species of the
cornea-permeable cyclic hemiacetal. The alpha-ketoamide warhead of SNJ-1945
binds with the hydroxyl group of the tetrahedral adduct pointing toward the
catalytic histidine rather than the oxyanion hole. The muI-II-SNJ-1945 complex
shows residue Glu261 displaced from the S1' site by the inhibitor, resulting in
an extended "open" conformation of the domain II gating loop and an
unobstructed S1' site. This conformation offers an additional template for
structure-based drug design extending to the primed subsites. An important role
for the highly conserved Glu261 is proposed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
I.O.Donkor
(2011).
Calpain inhibitors: a survey of compounds reported in the patent and scientific literature.
|
| |
Expert Opin Ther Pat, 21,
601-636.
|
 |
|
|
|
|
 |
Y.J.Yoo,
D.H.Nam,
S.Y.Jung,
J.W.Jang,
H.J.Kim,
C.Jin,
A.N.Pae,
and
Y.S.Lee
(2011).
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
|
| |
Bioorg Med Chem Lett, 21,
2850-2854.
|
 |
|
|
|
|
 |
H.Ma,
A.Tochigi,
T.R.Shearer,
and
M.Azuma
(2009).
Calpain inhibitor SNJ-1945 attenuates events prior to angiogenesis in cultured human retinal endothelial cells.
|
| |
J Ocul Pharmacol Ther, 25,
409-414.
|
 |
|
|
|
|
 |
B.T.Gonçalves,
P.M.Esteves,
A.C.Pinto,
C.R.Kaiser,
F.L.da Silva,
E.Miguez,
and
J.F.da Silva
(2008).
Anisotropic and hydrogen bonding effects in phenylglyoxamides and mandelamides: theoretical and NMR conformational evaluation.
|
| |
Magn Reson Chem, 46,
418-426.
|
 |
|
|
|
|
 |
I.O.Donkor,
H.Assefa,
and
J.Liu
(2008).
Structural basis for the potent calpain inhibitory activity of peptidyl alpha-ketoacids.
|
| |
J Med Chem, 51,
4346-4350.
|
 |
|
|
|
|
 |
I.O.Donkor,
and
R.Korukonda
(2008).
Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.
|
| |
Bioorg Med Chem Lett, 18,
4806-4808.
|
 |
|
|
|
|
 |
J.Qian,
D.Cuerrier,
P.L.Davies,
Z.Li,
J.C.Powers,
and
R.L.Campbell
(2008).
Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
|
| |
J Med Chem, 51,
5264-5270.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Azuma,
and
T.R.Shearer
(2008).
The role of calcium-activated protease calpain in experimental retinal pathology.
|
| |
Surv Ophthalmol, 53,
150-163.
|
 |
|
|
|
|
 |
D.Cuerrier,
T.Moldoveanu,
R.L.Campbell,
J.Kelly,
B.Yoruk,
S.H.Verhelst,
D.Greenbaum,
M.Bogyo,
and
P.L.Davies
(2007).
Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
|
| |
J Biol Chem, 282,
9600-9611.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.E.Croall,
and
K.Ersfeld
(2007).
The calpains: modular designs and functional diversity.
|
| |
Genome Biol, 8,
218.
|
 |
|
|
|
|
 |
H.K.Lorenzo,
and
S.A.Susin
(2007).
Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
|
| |
Drug Resist Updat, 10,
235-255.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|